Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC.SI · Entity 5607 | Director · CEO & Executive Chairman | September 14, 2026 | September 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SHOULDER INNOVATIONS, INC.
Report date September 14, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 390,999 |
Reported balance
After 2026-09-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-14 · Exercise / conversion · Acquired 89,233 · Balance 390,999 F1: Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 380,824 |
Reported balance
After 2026-09-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-14 · Sale · Disposed 10,175 · Balance 380,824 F2: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.22 to $18.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The shares of Common Stock were sold solely to cover the exercise price in connection with the exercise of the stock option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.10 · Expires 2030-12-16 | Direct | 92,143 |
Reported balance
After 2026-09-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-14 · Exercise / conversion · Disposed 89,233 · Balance 92,143 F3: The stock option is fully vested and currently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan.
F2: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.22 to $18.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The shares of Common Stock were sold solely to cover the exercise price in connection with the exercise of the stock option.
F3: The stock option is fully vested and currently exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 15, 2026 00:23 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 89,233 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0002070664-26-000006 · wk-form4_1789431783.xml · derivative · entry 3 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,143 Underlying: Common Stock · 89,233 shares Expires 2030-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 00:23 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | SaleCommon Stock | 10,175 | $18.45 | $187,706.37 |
DisclosureSEC source: 0002070664-26-000006 · wk-form4_1789431783.xml · nonDerivative · entry 2 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,824 F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $18.22 to $18.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The shares of Common Stock were sold solely to cover the exercise price in connection with the exercise of the stock option. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 00:23 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 89,233 | $2.10 | $187,282.22 |
DisclosureSEC source: 0002070664-26-000006 · wk-form4_1789431783.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,748 shares of Common Stock acquired on June 30, 2026 pursuant to the Issuer's 2025 Employee Stock Purchase Plan. Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:33 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0002070664-26-000005 · wk-form4_1777581232.xml · derivative · entry 2 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,756 Underlying: Common Stock · 10,000 shares Expires 2033-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested as to one-fourth of the underlying shares on May 17, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter. Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:33 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 10,000 | $2.48 | $24,804.00 |
DisclosureSEC source: 0002070664-26-000005 · wk-form4_1777581232.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the following shares received without consideration as in-kind distributions: (i) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (ii) 6,752 shares from Genesis Investment Holdings. In prior reports, the reporting person reported beneficial ownership of 278,866 shares of Shoulder Innovations common stock held directly. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:31 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | PurchaseCommon Stock | 2,200 | $15.18 | $33,392.04 |
DisclosureSEC source: 0002070664-26-000004 · wk-form4_1773783067.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,866 F1 · price: The price reported in Column 4 is a weighted average purchase price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $14.80 to $15.50, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth herein. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:24 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 2,062 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · derivative · entry 4 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,376 Underlying: Common Stock · 2,062 shares Expires 2030-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:24 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · derivative · entry 3 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,756 Underlying: Common Stock · 10,000 shares Expires 2033-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested as to one-fourth of the underlying shares on May 17, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:24 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 2,062 | $2.10 | $4,327.73 |
DisclosureSEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · nonDerivative · entry 2 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:24 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | Exercise / conversionCommon Stock | 10,000 | $2.48 | $24,804.00 |
DisclosureSEC source: 0002070664-26-000003 · wk-form4_1770758663.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the following shares received without consideration as in-kind distributions: (i) 110,331 shares from Genesis Investment Holdings; (ii) 7,859 shares from cultivate(MD) Capital Accelerator Fund, L.P.; (iii) 6,948 shares from Cultivate MD Capital Fund I, LLC; and (iv) 19,348 shares from Cultivate MD Capital Fund II, LP. In prior reports, the reporting person reported beneficial ownership of 120,118 shares of Shoulder Innovations common stock held directly. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:35 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | GrantStock Option · Derivative | 265,351 | $0.00 Strike: $14.16 | $0.00 |
DisclosureSEC source: 0002070664-26-000002 · wk-form4_1770154525.xml · derivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,351 Underlying: Common Stock · 265,351 shares Expires 2033-01-30 F1 · derivative.exercise_date: The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027. Read SEC document |
| December 31, 2025 Filed Jan 8, 2026 21:57 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | GrantCommon Stock | 1,661 | $12.16 | $20,197.76 |
DisclosureSEC source: 0002070664-26-000001 · wk-form4_1767909450.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,118 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2025 Employee Stock Purchase Plan ("ESPP") . F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2025. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 21:51 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | PurchaseCommon Stock | 3,900 | $14.89 | $58,075.29 |
DisclosureSEC source: 0001628280-25-057067 · wk-form4_1765835502.xml · nonDerivative · entry 2 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,457 F2 · price: The price reported in Column 4 is a weighted average purchase price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $14.60 to $15.26, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth herein. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:51 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | PurchaseCommon Stock | 3,300 | $14.83 | $48,934.05 |
DisclosureSEC source: 0001628280-25-057067 · wk-form4_1765835502.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,557 F1 · price: The price reported in Column 4 is a weighted average purchase price. The shares of Common Stock were purchased in multiple transactions at prices ranging from $14.56 to $15.16, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth herein. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:15 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | PurchaseCommon Stock | 6,000 | $15.49 | $92,945.40 |
DisclosureSEC source: 0001493152-25-013475 · ownership.xml · nonDerivative · entry 2 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,259 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.9196 to $15.815. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:15 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | PurchaseCommon Stock | 2,000 | $14.90 | $29,809.60 |
DisclosureSEC source: 0001493152-25-013475 · ownership.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,259 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.8096 to $15.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries E Convertible Preferred Stock · Derivative | 146,459 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 6 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,676 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries D Convertible Preferred Stock · Derivative | 706,572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 5 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries B Convertible Preferred Stock · Derivative | 387,346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 4 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries A Convertible Preferred Stock · Derivative | 176,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 3 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionSeries Seed Convertible Preferred Stock · Derivative | 222,304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022242 · ownership.xml · derivative · entry 2 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:05 UTC | SHOULDER INNOVATIONS, INC. SI · Entity 5607 | ConversionCommon Stock | 85,888 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-022242 · ownership.xml · nonDerivative · entry 1 Ball Robert Joseph · CIK 0002070664 · Director · CEO & EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.